FR15C0035I2 - 2-phenyl-1- 4-(2-aminoethoxy)-benzyl]-indole en combinaison avec des oestrogenes - Google Patents

2-phenyl-1- 4-(2-aminoethoxy)-benzyl]-indole en combinaison avec des oestrogenes

Info

Publication number
FR15C0035I2
FR15C0035I2 FR15C0035C FR15C0035C FR15C0035I2 FR 15C0035 I2 FR15C0035 I2 FR 15C0035I2 FR 15C0035 C FR15C0035 C FR 15C0035C FR 15C0035 C FR15C0035 C FR 15C0035C FR 15C0035 I2 FR15C0035 I2 FR 15C0035I2
Authority
FR
France
Prior art keywords
aminoethoxy
estrogens
indole
benzyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR15C0035C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22151320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR15C0035(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of FR15C0035I1 publication Critical patent/FR15C0035I1/fr
Application granted granted Critical
Publication of FR15C0035I2 publication Critical patent/FR15C0035I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR15C0035C 1998-05-15 2015-05-06 2-phenyl-1- 4-(2-aminoethoxy)-benzyl]-indole en combinaison avec des oestrogenes Active FR15C0035I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7956198A 1998-05-15 1998-05-15
PCT/US1999/010217 WO1999059581A1 (en) 1998-05-15 1999-05-11 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens

Publications (2)

Publication Number Publication Date
FR15C0035I1 FR15C0035I1 (OSRAM) 2015-06-26
FR15C0035I2 true FR15C0035I2 (fr) 2015-08-28

Family

ID=22151320

Family Applications (1)

Application Number Title Priority Date Filing Date
FR15C0035C Active FR15C0035I2 (fr) 1998-05-15 2015-05-06 2-phenyl-1- 4-(2-aminoethoxy)-benzyl]-indole en combinaison avec des oestrogenes

Country Status (41)

Country Link
EP (1) EP1076558B1 (OSRAM)
JP (3) JP2002515431A (OSRAM)
KR (1) KR100620772B1 (OSRAM)
CN (1) CN1230163C (OSRAM)
AP (1) AP1424A (OSRAM)
AR (1) AR020074A1 (OSRAM)
AT (1) ATE245026T1 (OSRAM)
AU (1) AU760378B2 (OSRAM)
BE (1) BE2015C026I2 (OSRAM)
BG (1) BG64783B1 (OSRAM)
BR (1) BR9911040A (OSRAM)
CA (1) CA2329530A1 (OSRAM)
CU (1) CU23241B7 (OSRAM)
CY (1) CY2015020I1 (OSRAM)
CZ (1) CZ299334B6 (OSRAM)
DE (1) DE69909616T2 (OSRAM)
DK (1) DK1076558T3 (OSRAM)
EA (1) EA005932B1 (OSRAM)
EE (1) EE04262B1 (OSRAM)
ES (1) ES2203131T3 (OSRAM)
FR (1) FR15C0035I2 (OSRAM)
GE (1) GEP20033079B (OSRAM)
HR (1) HRP20000778B1 (OSRAM)
HU (2) HU226587B1 (OSRAM)
ID (1) ID26890A (OSRAM)
IL (1) IL139130A (OSRAM)
IN (1) IN192220B (OSRAM)
LT (1) LTC1076558I2 (OSRAM)
LU (1) LU92699I2 (OSRAM)
NO (2) NO328129B1 (OSRAM)
NZ (1) NZ508200A (OSRAM)
OA (1) OA11552A (OSRAM)
PL (1) PL194750B1 (OSRAM)
PT (1) PT1076558E (OSRAM)
SI (1) SI1076558T1 (OSRAM)
SK (1) SK284666B6 (OSRAM)
TR (1) TR200003377T2 (OSRAM)
TW (1) TW565554B (OSRAM)
UA (1) UA66861C2 (OSRAM)
WO (1) WO1999059581A1 (OSRAM)
ZA (1) ZA200006959B (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515431A (ja) * 1998-05-15 2002-05-28 アメリカン・ホーム・プロダクツ・コーポレイション エストロゲンと組み合わせる２−フェニル−１−［４−（２−アミノエトキシ）ベンジルオキシ］インドール
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
MX270786B (es) 1999-07-06 2009-10-08 Endorech Inc Metodos de tratamiento y/o supresion del incremento de peso.
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
MXPA02012896A (es) * 2000-07-06 2003-10-24 Wyeth Corp Combinaciones de estatinas, agentes estrogenicos y opcionalmente estrogenos.
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
WO2002003976A2 (en) * 2000-07-06 2002-01-17 Wyeth Combinations of bisphosphonates, estrogenic agents and optionally estrogens
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
WO2002003992A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating prosthesis-related bone degeneration
WO2002003989A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating sphincter incontinence
DE10117441A1 (de) * 2001-04-03 2002-10-10 Schering Ag 1-Indolylderivate, deren Verwendung zur Herstellung von Arzneimitteln, ein Verfahren zur Herstellung der 1-Indolylderivate sowie 1-Indolylderivate enthaltende pharmzeutische Präparate
CN1599606A (zh) 2001-07-31 2005-03-23 辉瑞产品公司 包含雌激素激动剂/拮抗剂、雌激素与孕激素组合的药物组合物、试剂盒和方法
KR100470274B1 (ko) 2002-11-08 2005-02-05 진 장 덮개층을 이용한 비정질 물질의 상 변화 방법
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
MX2010011408A (es) 2008-04-16 2010-12-20 Karobio Ab Ligandos de receptor de estrogeno novedosos.
AR072297A1 (es) * 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
CN102690225B (zh) * 2012-04-11 2014-12-24 南京友杰医药科技有限公司 巴多昔芬的合成方法
CN103709090A (zh) * 2014-01-16 2014-04-09 江苏万特制药有限公司 醋酸巴多昔芬的制备方法及其关键中间体
CN103739540B (zh) * 2014-01-20 2016-05-04 华润赛科药业有限责任公司 一种醋酸巴多昔芬中间体的制备方法
CN105669518B (zh) * 2014-12-04 2019-06-04 上海医药集团股份有限公司 醋酸巴多昔芬及其a晶型的制备方法
CN111527080B (zh) * 2017-12-15 2023-09-22 百时美施贵宝公司 取代的吲哚醚化合物
IT201800006562A1 (it) * 2018-06-21 2019-12-21 Procedimento e intermedi utili per la preparazione di indoli
JP2023517393A (ja) * 2020-03-17 2023-04-25 メッドシャイン ディスカバリー インコーポレイテッド タンパク質分解調整剤およびその使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
CA2135160A1 (en) * 1992-05-08 1993-11-25 Masatoshi Inai Indole derivative
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
GB9326332D0 (en) * 1993-12-23 1994-02-23 Karo Bio Indole derivatives
DE4426625A1 (de) * 1994-07-27 1996-03-14 Schering Ag 2-Phenylindole, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
ATE206701T1 (de) * 1996-04-19 2001-10-15 American Home Prod Östrogene verbindungen
IL127668A0 (en) * 1996-07-09 1999-10-28 Smithkline Beecham Spa Indole derivatives for the treatment of osteoporosis
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
CA2306343C (en) * 1997-10-15 2010-08-03 American Home Products Corporation Novel aryloxy-alkyl-dialkylamines
AU1197299A (en) * 1997-10-28 1999-05-17 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
ID24568A (id) * 1997-11-06 2000-07-27 American Home Prod Kontrasepsi oral yang mengandung anti-estrogen plus progestin
JP2002515431A (ja) * 1998-05-15 2002-05-28 アメリカン・ホーム・プロダクツ・コーポレイション エストロゲンと組み合わせる２−フェニル−１−［４−（２−アミノエトキシ）ベンジルオキシ］インドール

Also Published As

Publication number Publication date
BE2015C026I2 (en) 2018-08-24
JP2009019042A (ja) 2009-01-29
IL139130A0 (en) 2001-11-25
OA11552A (en) 2004-06-07
DE69909616D1 (de) 2003-08-21
PL345268A1 (en) 2001-12-03
BR9911040A (pt) 2001-02-13
PL194750B1 (pl) 2007-06-29
JP5607871B2 (ja) 2014-10-15
SI1076558T1 (en) 2003-10-31
EE200000652A (et) 2002-04-15
HRP20000778A2 (en) 2001-06-30
EP1076558B1 (en) 2003-07-16
AP1424A (en) 2005-06-06
JP2014159472A (ja) 2014-09-04
HRP20000778B1 (en) 2004-10-31
CA2329530A1 (en) 1999-11-25
CY2015020I1 (el) 2020-05-29
ES2203131T3 (es) 2004-04-01
CZ20004254A3 (cs) 2001-12-12
HK1031691A1 (en) 2001-06-22
HU226587B1 (en) 2009-04-28
SK284666B6 (sk) 2005-08-04
LU92699I2 (fr) 2015-06-24
AR020074A1 (es) 2002-04-10
CN1326347A (zh) 2001-12-12
HUP0103096A2 (hu) 2002-05-29
JP2002515431A (ja) 2002-05-28
TR200003377T2 (tr) 2001-03-21
IN192220B (OSRAM) 2004-03-20
EA005932B1 (ru) 2005-08-25
IL139130A (en) 2005-11-20
NO2015015I2 (no) 2015-06-02
DE69909616T2 (de) 2004-06-17
DK1076558T3 (da) 2003-11-03
NO328129B1 (no) 2009-12-14
CU23241B7 (es) 2007-10-17
AU3894499A (en) 1999-12-06
CN1230163C (zh) 2005-12-07
EE04262B1 (et) 2004-04-15
CZ299334B6 (cs) 2008-06-25
EP1076558A1 (en) 2001-02-21
AP2000001970A0 (en) 2000-12-31
EA200001193A1 (ru) 2001-12-24
BG104930A (en) 2001-07-31
AU760378B2 (en) 2003-05-15
ATE245026T1 (de) 2003-08-15
HUP0103096A3 (en) 2002-11-28
NO20005770L (no) 2001-01-12
PT1076558E (pt) 2003-11-28
ID26890A (id) 2001-02-15
UA66861C2 (uk) 2004-06-15
LTC1076558I2 (lt) 2016-11-10
SK17202000A3 (sk) 2001-07-10
KR20010043641A (ko) 2001-05-25
NZ508200A (en) 2003-09-26
JP5872624B2 (ja) 2016-03-01
BG64783B1 (bg) 2006-04-28
KR100620772B1 (ko) 2006-09-13
NO2015015I1 (no) 2015-06-02
HUS1500023I1 (hu) 2017-03-28
TW565554B (en) 2003-12-11
FR15C0035I1 (OSRAM) 2015-06-26
GEP20033079B (en) 2003-10-27
WO1999059581A1 (en) 1999-11-25
ZA200006959B (en) 2001-11-27
NO20005770D0 (no) 2000-11-14

Similar Documents

Publication Publication Date Title
FR15C0035I2 (fr) 2-phenyl-1- 4-(2-aminoethoxy)-benzyl]-indole en combinaison avec des oestrogenes
FI20010777L (fi) Istuintilayksikkö
DE59904239D1 (de) Sitzvorrichtung
DE69909284D1 (de) Verbesserungen bei koaleszierfilter
DE69830382D1 (de) Sicheres Drucken
NO994378L (no) Batteriladeranordning
DE59902737D1 (de) Zweikomponentenbehälter
DE69812876D1 (de) Brennstoffzufuhrvorrichtung
DE69912207D1 (de) Fluoroelastomere
NO20011957D0 (no) Bildedekoder
DE59902536D1 (de) Zweikomponentenbehälter
DE69907677D1 (de) Brennstoff-luft-mischgerät
DE69909386D1 (de) Konkave Ablenkplatte
DE59808625D1 (de) Toiletteneinheit
DE69908330D1 (de) 5-heteroaryl-substituierte indole
FI20001646L (fi) Sovitelma rummun yhteydessõ
ATA126099A (de) Absperrarmatur
DE60118970D1 (de) Indol- und dihydroindolderivate
DE69912593D1 (de) Sitzeinrichtung
ATA32198A (de) Beschlag
DE59903236D1 (de) Bogenleiteinrichtung in der Bogenanlage
ATA135698A (de) Transporteinrichtung
FR2794192B1 (fr) Ventilateur avec rondelle-entretoise
FR2787616B1 (fr) Calicot multi-messages
FI982312A0 (fi) Sovitelma sammutusjärjestelmän yhteydessä